Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

6.06
Delayed Data
As of May 05
 -0.07 / -1.14%
Today’s Change
5.50
Today|||52-Week Range
11.40
-19.63%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close6.13
Today’s open6.20
Day’s range5.62 - 6.28
Volume11,366
Average volume (3 months)10,483
Market cap$27.8M
Dividend yield--
Data as of 3:47pm ET, 05/05/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+34.64%
P/E ratio15.8
Price/Sales2.32
Price/Book1.92

Competitors

 Today’s
change
Today’s
% change
GENEGenetic Technologies...0.000.00%
KDUSCadus Corp-0.02-1.87%
SNGXSoligenix Inc+0.02+2.44%
XTNTXtant Medical Holdin...-0.02-0.89%
Data as of 4:00pm ET, 05/05/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$10.2M
Annual profit (last year)$1.2M
Net profit margin11.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts

Partner Offers

Search for Jobs